Pancreatic Cancer Palliative Library Therapy is a brand new therapy with the effect of surgery, immunotherapy and chemotherapy. Slow-release depot therapy changes the traditional way of drug delivery as well as treatment means, and is used for the treatment of solid tumors, mainly through CT or B ultrasound and other imaging, the anti-cancer drugs will be injected into the tumors and slowly released in the body, so as to alleviate the pain, discomfort and other symptoms of pancreatic cancer patients. It can effectively prolong the survival time and improve the quality of patients’ survival. Pancreatic cancer slow-release depot therapy is suitable for use in patients with failed surgery, postoperative recurrence, and those who have developed a condition that appears to be metastatic. It should be prohibited for patients with obstructive jaundice, liver metastasis and more intense low back pain. Pancreatic cancer patients should pay attention to appropriate rest during the treatment and avoid overwork. Since the occurrence of pancreatic cancer may affect the hematopoietic function of the patients, so do a good job of personal protection measures in daily life.